Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: KPC Pharmaceuticals,Inc.

Market Cap 6.26B 924M 808M 747M 697M 1.31B 87.34B 1.32B 8.88B 3.45B 42.94B 3.47B 3.39B 149B P/E 2026 *
19.2x
P/E 2027 * 15.2x
Enterprise Value 6.26B 924M 808M 747M 697M 1.31B 87.34B 1.32B 8.88B 3.45B 42.94B 3.47B 3.39B 149B EV / Sales 2026 *
0.92x
EV / Sales 2027 * 0.87x
Free-Float
60.48%
Yield 2026 *
-
Yield 2027 * -
1 day-0.74%
1 week-5.86%
Current month-10.08%
1 month-4.74%
3 months-31.43%
6 months-35.71%
Current year-36.07%
1 week 7.76
Extreme 7.76
8.39
1 month 7.76
Extreme 7.76
9.69
Current year 7.76
Extreme 7.76
13.55
1 year 7.76
Extreme 7.76
15.08
3 years 7.76
Extreme 7.76
24.11
5 years 7.76
Extreme 7.76
26.09
10 years 5.95
Extreme 5.95
26.09
Manager TitleAgeSince
Director of Finance/CFO - 2023-01-02
President 55 2023-09-27
Corporate Officer/Principal 54 2007-05-31
Director TitleAgeSince
Chairman 59 2023-01-18
Director/Board Member 64 2009-10-31
Director/Board Member 55 2023-10-17
Change 5-day change 1-year change 3-year change Capi.($)
-0.74%-5.86%-45.34%-61.39% 897M
+0.32%-2.41%+44.49%+140.80% 983B
+1.27%-1.85%+54.41%+39.65% 557B
+6.25%+3.80%+24.13%+67.39% 406B
+1.27%-1.93%+23.33%+16.35% 314B
+2.22%+1.90%+29.90%+18.51% 273B
+2.04%+2.31%+28.80%+35.03% 272B
+2.29%+8.90%-32.26%-43.91% 203B
+2.11%-1.66%+19.14%+50.10% 186B
+0.90%+0.46%+15.09%+59.86% 155B
Average +1.14%-1.41%+16.17%+32.24% 335.12B
Weighted average by Cap. +1.12%-2.22%+31.77%+64.81%

Financials

2026 *2027 *
Net sales 6.8B 1B 877M 811M 757M 1.42B 94.84B 1.43B 9.64B 3.75B 46.63B 3.77B 3.69B 162B 7.23B 1.07B 933M 863M 806M 1.51B 101B 1.52B 10.26B 3.99B 49.62B 4.01B 3.92B 172B
Net income 317M 46.74M 40.84M 37.78M 35.26M 66.19M 4.42B 66.68M 449M 175M 2.17B 175M 172M 7.54B 400M 59.05M 51.6M 47.73M 44.55M 83.63M 5.58B 84.25M 567M 221M 2.74B 222M 217M 9.53B
Net Debt - -
Logo KPC Pharmaceuticals,Inc.
KPC Pharmaceuticals Inc is a China-based company primarily engaged in the research, development, manufacturing and sales of pharmaceuticals. The Company operates mainly through two segments. The Pharmaceutical segment focuses on the research and development and manufacturing of drugs for cardiovascular and cerebrovascular treatments, orthopedics, antimalarial drugs, gynecological drugs and digestive system drugs. The Pharmaceutical Wholesale segment is primarily engaged in the wholesale and retail of pharmaceuticals and medical devices. The Company conducts business in both domestic and overseas markets.
Employees
5,072
Date Price Change Volume
26-06-22 CN¥8.030 -0.74% 8,389,700
26-06-18 CN¥8.090 -1.34% 5,323,600
26-06-17 CN¥8.200 -2.15% 5,366,934
26-06-16 CN¥8.380 -1.76% 4,451,300
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
8.030CNY
Average target price
16.15CNY
Spread / Average Target
+101.12%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600422 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!